Table 2 Baseline patient characteristics and NT-proCNP serum concentrations
Parameter | All patients | Sepsis | Non-sepsis |
|---|---|---|---|
Number | 273 | 197 | 76 |
Sex (male/female) | 172/101 | 128/69 | 44/32 |
Age median (range) (years) | 64 (18-90) | 65 (20-90) | 60 (18-85) |
APACHE-II score median (range) | 17 (2-40) | 18 (3-40) | 15 (2-31) |
SAPS2 score median (range) | 44 (0-80) | 44.5 (0-79) | 41.5 (13-80) |
ICU days median (range) | 9 (0-137) | 12 ** (0-137) | 6 ** (1-45) |
Hospital days median (range) | 27 (2-151) | 30 ** (2-151) | 14 ** (2-85) |
Death during ICU n (%) | 76 (27.8%) | 61 (31.0%) | 15 (19.7%) |
Death during follow up n (%) | 132 (50.2%) | 101 (53.2%) | 31 (42.5%) |
Mechanical ventilation n (%) | 194 (73.2%) | 144 (75%) | 50 (68.5%) |
Ventilation time median (range) (hours) | 126 (0-2966) | 180 * (0-2966) | 48.5 (0-986) |
Pre-existing diabetes n (%) | 88 (33.1%) | 60 (31.3%) | 28 (37.8%) |
BMI median (range) (m²/kg) | 25.8 (14.0-66.7) | 25.9 (14.0-66.7) | 25.8 (15.9-53.3) |
NT-proCNP day 1 median (range)(pmol/L) | 4.07 (0-42) | 5.6 (0-42) ** | 1.48 (0-42) ** |
NT-proCNP day 3 median (range)(pmol/L) | 4.79 (0-42) | 5.81 (0-42) * | 0.90 (0-42) * |
NT-proCNP day 7 median (range)(pmol/L) | 3.91 (0-42) | 4.59 (0-42) | 2.37 (0-41.34) |